Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
Biochem Pharmacol
; 208: 115405, 2023 02.
Article
em En
| MEDLINE
| ID: mdl-36603686
Palavras-chave
Aquaporin; Cardiolipin; Cardiovascular diseases; Drug-Repurposing; Genomics; Hypertension; Ischemia reperfusion injury; Metabolomics; Mitochondrial carriers; Mitochondrial diseases; Mitochondrial dynamics; Mitochondrial dysfunction; Mitochondrial impairment; Mitochondrial metabolite transport system; Mitochondrial permeability transition pore; Mitochondrial pharmacological targets; Mitochondrial pyruvate carrier; Mitochondrial targets for CVD treatments; Molecular modeling of mitochondrial proteins; Respiratory chain; Transcriptomics; Voltage-dependent anion channels
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
/
Traumatismo por Reperfusão
/
Hipertensão
Limite:
Humans
Idioma:
En
Revista:
Biochem Pharmacol
Ano de publicação:
2023
Tipo de documento:
Article